Myocardial Injury Is Associated with the Incidence of Major Adverse Cardiac Events in Patients with Severe Trauma

Alexandra Stroda1, Carina Jaekel2, René M'Pembele1

  • 1Department of Anesthesiology, Medical Faculty, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, 40225 Dusseldorf, Germany.

Insights

Myocardial injury in severe trauma patients is linked to higher risks of major adverse cardiac events (MACE) and acute kidney injury (AKI). This study highlights the importance of assessing cardiac health following trauma.

Area of Science:

  • Cardiology
  • Trauma Medicine
  • Critical Care

Background:

  • Severe trauma can lead to end-organ damage, including myocardial injury.
  • Myocardial injury in trauma patients is associated with increased mortality.
  • The link between myocardial injury and in-hospital major adverse cardiac events (MACE) in trauma patients is not well-established.

Purpose of the Study:

  • To investigate the association between myocardial injury at presentation and the incidence of in-hospital MACE in severe trauma patients.
  • To determine the association between myocardial injury and the incidence of acute kidney injury (AKI) within 72 hours.

Main Methods:

  • Retrospective cohort study of adult severe trauma patients (January 2016 - December 2019).
  • Primary exposure: myocardial injury at presentation.
  • Outcomes: in-hospital MACE and AKI within 72 hours.
  • Statistical analysis included receiver operating characteristic (ROC) curve analysis for hsTnT discrimination and multivariate logistic regression.

Main Results:

  • 353 patients included; 72.5% male, mean age 55 years.
  • Area under the curve (AUC) for hsTnT predicting MACE was 0.68; for AKI, it was 0.64.
  • Myocardial injury was independently associated with MACE (adjusted OR 2.97) and AKI (adjusted OR 2.14).

Conclusions:

  • Myocardial injury at presentation in severe trauma patients is an independent predictor of in-hospital MACE.
  • Myocardial injury is also independently associated with the incidence of AKI in this patient population.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
229
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
34
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20